Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,133,158
-$31,693,422 QoQ
Shares Held
396,480
-76.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Intesa Sanpaolo S.p.A. holds $313,556,216 across 11 Drug Manufacturers - General names. PFE ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,163,193 | $229,404,923 | |
| 2 | LLY |
ELI LILLY & Co
|
21,958 | $20,196,309 | |
| 3 | ABBV |
AbbVie Inc.
|
84,186 | $18,309,613 | |
| 4 | JNJ |
Johnson & Johnson
|
67,799 | $16,572,787 | |
| 5 | PFE |
Pfizer Inc
This page
|
396,480 | $11,133,158 | |
| 6 | MRK |
Merck & Co., Inc.
|
68,892 | $8,287,018 | |
| 7 | AMGN |
Amgen Inc
|
15,269 | $5,372,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,900 | $3,470,313 |
All Filings in PFE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,133,158 | 396,480 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,826,580 | 1,719,943 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||